In a retrospective survey of all adults admitted to the Intensive Care Unit with acute theophylline poisoning over the last five years, we identified 38 patients (6.8% of all admissions for poisoning), two of whom died. Thirty-five (92%) had taken a sustained-release preparation. Eight patients had grand mal seizures and six developed arrhythmias (ventricular fibrillation, 3; atrial fibrillation, 2; supraventricular tachycardia, 1). Severe vomiting was present in 34 (89%) and proved to be a serious obstacle to the administration of enteral charcoal. The vomiting was controlled by intravenous metoclopramide in seventeen patients (50%), but the remaining seventeen required mechanical ventilation with sedation and muscle relaxation for the effective delivery of nasogastric charcoal. Importantly, in nine (24%), the serum theophylline concentration continued to rise despite enteral charcoal. Charcoal haemoperfusion was used in seven (18%). We present an algorithm for the management of severe, acute theophylline poisoning.
suggested a modified algorithm for the management of severe acute theophylline poisoning in adults (Figure 4 ).
METHODS
The Princess Alexandra Hospital (P AH) is a thousand-bed adult Teaching Hospital in an urban area of Brisbane. The computerised records of all patients admitted to the Intensive Care Unit between January 1986 and December 1990 were reviewed. All patients with a diagnosis of acute theophylline overdose, in whom the peak serum theophylline concentration exceeded 20 mg/l (110 mmolll), were included in the study. Clinical data including age, gender, intercurrent illnesses, medications, formulation of theophylline, approximate time of ingestion, and symptoms and signs of toxicity, as well as laboratory data, were recorded. The latter included white cell count, arterial blood pH, serum glucose, sodium, potassium, urea, calcium, phosphate and bicarbonate. Serum theophylline concentrations, measured by the Abbott TDX assay, were recorded on admission and serially thereafter. In addition, all patients had a twelve-lead ECG followed by continuous ECG monitoring, and a chest X-ray.
The data were recorded and analysed using DBase IV (Ashton-Tate, CA). Statistical manipulations were carried out using the SSPS/PC (SSPS Inc., 11.) . RESULTS During the five-year study period, 559 overdose patients were admitted to the ICV, of whom 38 (6.8%) had taken a single large dose oftheophylline. Of the seven deaths from poisoning, two were due to theophylline (29%). The mean age of those taking theophylline (27.6 years, SO 11.6 ) was similar to that of those who had ingested other compounds (27.6 years, SO 12.35 ). There was a preponderance of males in the theophylline (M:F = 1. 7: 1) compared to the non-theophylline group (M:F = 0.8:1). The patients spent 1.65±1.04 days in the ICV and the survivors a total of 4.2±5.8 days in hospital. All survivors were seen in consultation by a psychiatrist. Thirty-six were then discharged home and two to the Psychiatric Unit.
The relevant characteristics of the theophyllinetoxic patients and details of management are presented in Table 1 4 Reproduced in modified form, with kind permission, American Journal of Emergency Medicine. Anaesthesia and Intensive Care, Vol. 20, No. I, February, 1992 other toxic compounds: alcohol, 8; alcohol plus benzodiazepines, 3; benzodiazepines, 3; aspirin, 1; naproxen, 1; paracetamol, 1; and amitriptyline, 1. Twenty-five had a concomitant illness: asthma, 25; chronic obstructive airways disease, 2; schizophrenia, 1; and epilepsy in a patient with asthma, 1. Clinically, the patients presented with the typical picture of agitation, sweating, tremor and vomiting. Marked sinus tachycardia was present in 35 (92%).
All patients with acute overdose were enrolled into a separate trial of efficacy of gastric emptying. Of the patients taking theophylline, seven were given syrup of ipecac, twelve had gastric lavage, nineteen had no gastric emptying procedure performed. Management was then along the lines described by Olson et al. 4 (Figure 1 ), except that the initial dose of activated charcoal was 50 g in 150 ml 70% sorbitol (Delta West, Australia). Subsequent doses were also 50 g and given with sorbitol until sorbitol-induced diarrhoea was evident.
Haemoperfusion was begun using cartridges containing activated charcoal (Gambro Adsorba 3000, Gambro, France) in nine patients (Table 1) . Haemoaccess was obtained via the subclavian vein using a double-lumen catheter (Vas-cath, Ontario, Canada) and the patients were anticoagulated with heparin, 5000 units as a bolus followed by an infusion of 10 units/kg/hour. The serum theophylline concentrations in all of these patients are shown in Table 1 . In two patients (#24 and #26), the blood lines clotted after about an hour of haemoperfusion and a second cartridge was not used. Both of these patients were changed to pumpdriven haemofiltration during which the ultrafiltration rate was 1.2 IIhour. The serum theophylline concentration profile for patient #24 is shown in Figure 2 . Over the fourteen-hour period of haemofiltration, only 1.14 g of theophylline was recovered from the filtrate. Assuming a one compartment model and that the volume distribution of theophylline was 0.5 IIkg, and multiplying this volume by the serum theophylline concentration over the same fourteen-hour period, the total amount of theophylline eliminated from the body was 4.6 g. These figures suggest that 75% of the theophylline was eliminated endogenously, showing that haemofiltration had a low efficacy in removing theophylline and that it cannot be used as a substitute for haemoperfusion. Two patients from distant hospitals with initial serum theophylline concentrations of > 100 mgil were not haemoperfused because the serum theophylline concentration had fallen substantially by the time of admission to our hospital.
Several problems complicated management in the ICU. 
Characteristics of patients on presentation and during therapy in the Intensive Care Unit

Vomiting
On admission to the ICU, thirty-four patients (89%) had severe, repetitive vomiting. Four of these patients also had small haematemeses thought to be due to Mallory Weiss tears. The serum theophylline concentration on presentation was higher in those with vomiting (mean value, 85.6 mg/l) compared to those without (48 mg/l; Wilcoxon rank sum test; P= 0.01).
Intravenous metoclopramide (10 mg) controlled the vomiting in seventeen (50%) and allowed the effective delivery of charcoal, orally or by nasogastric tube. In the remaining seventeen who had persistent vomiting despite this manoeuvre, mechanical ventilation was necessary to protect the airway and to facilitate the administration of nasogastric charcoal. A rapid-sequence induction using fentanyl 100 /J.g, or midazolam 10 mg, followed by suxamethonium 1.0 mglkg, was used. Sedation and muscle relaxation were maintained according to the unit protocol with an infusion of omnopon 1.0 to 5 mglhr and bolus intravenous doses ofpancuronium, 2 to 6 mg. The mean time of mechanical ventilation was 37±105 hours (range 5-178) and the procedure had no morbidity.
Continued absorption of theophylline
The serum theophylline concentration continued to rise after admission to ICU, despite enteral Anaesthesia and Intensive Care, Vol. 20, No. I, February, 1992 charcoal, in nine patients. In one patient (patient #2), a very rapid increase in the serum theophylline concentration occurred leading to fatal ventricular fibrillation.
Abnormalities in serum potassium concentrations
The serum potassium concentration at the time of presentation was < 3.5 mmol/l in 31 patients (3.08±0.54, range 2.3-4.9 mmol/l). All patients were given intravenous potassium, the mean dose over the first twelve hours being 58±25.6 mmol (range 20-160 mmol). Within 18 to 24 hours, five of these patients developed mild hyperkalaemia, the concentrations ranging from 5.1 to 7.4 mmol/l. Arrhythmias Six patients developed arrhythmias. Two of the three with ventricular fibrillation responded immediately to DC fibrillation, followed by haemoperfusion; the third died from refractory ventricular fibrillation. Two developed atrial fibrillation which responded rapidly to intravenous metoprolol 2 mg. One of these patients (patient #38) died later of multiple organ failure. One patient developed a supraventricular tachycardia which did not respond to an intravenous bolus of verapamil 15 mg followed by an infusion at 5 mg/hour. Verapamil was chosen because of concomitant asthma.
Cardioversion was not required on haemodynamic grounds and the arrhythmia settled after two hours of haemoperfusion.
Seizures
Eight patients developed grand mal seizures. Of these, six had peak serum theophylline concentrations that exceeded 90 mgll, whereas two had lower values, 50 and 43 mgll (patients #9 and 30, respectively). Patient #30, however, was known to have a history of epilepsy. One patient (patient #24), who presented with status epilepticus, developed massive rhabdomyolysis and acute renal failure. In all patients the seizures responded promptly to the administration of intravenous diazepam (10-15 mg). The patient with epilepsy (patient #30) was also given intravenous phenytoin (1.0 g over 60 minutes). Long-term follow-up, possible in four of these patients (patients # 1, 24, 30, 32), revealed that they had recovered without obvious neurological sequelae, although formal psychometric testing was not performed.
Death
Two patients died. The first (patient #2) was a 35-year-old male who took 20 g of sustained-release theophylline as well as an unknown amount of ethanol about 3.5 hours before admission. The serum theophylline concentration on admission was 72 mgll and the serum ethanol 9 mmol/l. As discussed above, the serum theophylline concentrations continued to rise, despite incessant vomiting and the administration of activated charcoal. Five hours after the ingestion, the patient had a grand mal seizure, followed by refractory ventricular fibrillation. The serum theophylline concentration at the time of death was 148 mgll (814 Ilmol/l).
The second patient (patient #38) was a 57-yearold male who ingested sustained-release aspirin 20 g and about 240 g ethanol about three hours before his first admission. The patient, who had a history of chronic obstructive airways disease, discharged himself from hospital against medical advice nine hours later. The serum concentration of salicylate was 186 mgll (therapeutic range 130-300 mgll). Twenty-four hours after the initial presentation, he returned to hospital having taken 25 g sustainedrelease theophylline. The serum theophylline concentration on presentation was 97 mgll. Before admission to ICU he developed a broad complex irregular tachycardia consistent with atrial fibrillation, and a right bundle branch block, for which digoxin 0.5 mg was given intravenously. The arrhythmia returned when he reached the ICU and responded to intravenous metoprolol 2 mg. Because of continued agitation and vomiting, he was intubated and maintained on mechanical ventilation for the remainder of the hospital stay. Despite enteral charcoal, the serum theophylline concentration remained high for several hours (Figure 3 ). He developed a severe paralytic ileus on the second day and he died from multiorgan failure on the fourth day. 
DISCUSSION
Theophylline was the leading cause of death from drug overdose in our Intensive Care Unit over the five-year study period (1986) (1987) (1988) (1989) (1990) . Management of toxicity in general followed the algorithm published previously by Olson et al. (Figure 1 ), 4 except that gastric lavage was not performed in every patient because a prospective trial of the efficacy of gastric emptying procedures was being undertaken at the hospital. Until the results of this large trial become available, we would support the recommendation of Olson that all patients taking an overdose of sustained-release theophylline should have gastric lavage as part of their initial resuscitation.
An important step in the treatment algorithm is the use of multi dose enteral charcoal to decontaminate the gastrointestinal tract. 1 0- 13 We added a cathartic (sorbitol) to reduce the risk of intestinal obstruction due to inspissated charcoal. We encountered two problems with the use of enteral charcoal.
First, theophylline-induced vomiting in 34 patients made the administration of the first or subsequent doses of charcoal difficult. In seventeen patients, conventional measures including the use of intravenous metoclopramide and a nasogastric tube allowed the safe delivery of enteral charcoal. In the remaining seventeen however, vomiting was only controlled by the use of mechanical ventilation. We therefore recommend the early use of mechanical ventilation with sedation and muscle relaxation to protect the airway and allow the effective delivery of enteral charcoal, in any patient in whom vomiting continues after the use of an anti-emetic and a nasogastric tube.
The second problem we noted in nine patients was that the serum theophylline concentration rose after admission, despite the administration of at least one dose of charcoal. This phenomenon was related to the protracted absorption of the sustained-release theophylline. 14 Serial measurements of serum theophylline concentrations led to early detection of this trend in three patients (#15,21,28), all of whom were then treated successfully with charcoal haemoperfusion. However, in patient #2, the rapidly rising serum theophylline concentration was not detected before fatal ventricular fibrillation developed. We therefore strongly recommend that serial (twohourly) serum theophylline levels should be measured in any patient who has taken a sustainedrelease preparation of theophylline, even if enteral charcoal administration has been effected.
Olson et al. 4 reserved charcoal haemoperfusion for patients with acute theophylline poisoning who demonstrated major complications, such as arrhythmias or seizures, or for those with serum theophylline concentrations approaching or exceeding 100 mg/I. Other authors have made similar recommendations, although the threshold serum theophylline concentration for haemoperfusion has varied from 80 mg/l to 100 mg/I. 4, 7, 8, 15, 16 The experience of our series supports this selective use ofhaemoperfusion. Although well recognised as complications ofhaemoperfusion, we did not experience any clinically significant problems with hypocalcaemia, neutropenia or thrombocytopenia. 6
Seizures and major arrhythmias require management along conventional lines using intravenous diazepam and a beta-adrenergic blocking drug, metoprolol, respectively,5.6 as well as urgent haemoperfusion as mentioned above. 4 of theophylline poisoning, was present in 31 (82%) of our patients. As the predominant mechanism is redistribution of potassium into cells, rather than whole body depletion,17 the need for potassium supplementation is controversial. Some authors recommend aggressive potassium replacement, 18 while others warn of the consequences of rebound hyperkalaemia. 4 In our series, in which all the patients received some intravenous potassium supplementation, asymptomatic hyperkalaemia occurred within the first 18 to 24 hours of admission in five patients (13%). Our current policy is to use cautious potassium supplementation if the initial serum potassium concentration is under 3 mmol/l, and to monitor serum electrolyte concentrations every four hours. Our experience has led us to modify the algorithm (Figure 1 ) for the treatment of theophylline poisoning to that shown in Figure 4 . It is important to note that this algorithm pertains only to large single overdoses, as there are important clinical and biochemical differences between patients with acute single overdoses and those suffering chronic theophylline overmedication. 4 With regard to the prevention of theophylline self-poisoning, two avenues are open. First, the use of theophylline might be curtailed and reserved for patients not fully responsive to the safer and more efficacious inhaled beta-agonists and corticosteroids.1 9 • 22 Second, the amount of theophylline taken by adults during an impulsive overdose might be reduced by dispensing the drug in blister packages. While this approach in adults is still conjectural, similar safety packaging of tricyclic antidepressants has been shown to reduce the frequency of severe poisoning in children. 23 At present in Australia, only one of the five sustainedrelease preparations of theophylline is marketed in blister packing.
